{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T23:39:48Z","timestamp":1792798788417,"version":"4.5.0"},"reference-count":70,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T00:00:00Z","timestamp":1792713600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T00:00:00Z","timestamp":1792713600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Support Care Cancer"],"published-print":{"date-parts":[[2026,11]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>Hematopoietic stem cell transplantation (HSCT) remains the primary curative option for many hematologic malignancies, yet its substantial risks make the treatment decision highly complex and high stakes for patients. Although current qualitative studies have explored how patients perceive HSCT, a comprehensive synthesis of these insights is still lacking. This study synthesizes existing research on patient perceptions of HSCT to guide shared decision-making in clinical practice.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A literature search was conducted across eight databases: PubMed, CINAHL, PsycARTICLES, Web of Science, Embase, the Cochrane Library, Scopus, and ProQuest Dissertations &amp; Theses Global, spanning from their respective inceptions to February 2026. The Joanna Briggs Institute criteria for qualitative research were utilized to evaluate the quality of the studies, and a content analysis approach was employed to integrate the findings.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A total of 20 studies were included, yielding 4 new integrated findings: (1) constrained choices; (2) decision-making embedded in relational contexts; (3) the hidden toll: financial constraints and logistical hurdles; (4) concerns about restricted social participation and threats to identity caused by transplantation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>HSCT decision-making is shaped not only by clinical risks and benefits, but also by constrained choice, relational contexts, practical circumstances, and concerns about future life. SDM-based decision support should therefore extend beyond information provision to clarify patients\u2019 understanding of the decision space, identify factors that constrain choice, and address the values and longer-term concerns that matter to them.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s00520-026-11381-8","type":"journal-article","created":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T06:21:11Z","timestamp":1792736471000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The perceptions of hematopoietic stem cell transplantation decision-making in patients with hematologic malignancies: a qualitative systematic review"],"prefix":"10.1007","volume":"34","author":[{"given":"QingYing","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"DanQi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"ShuQi","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pan","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4674-4000","authenticated-orcid":false,"given":"HuaFen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,23]]},"reference":[{"issue":"1","key":"11381_CR1","doi-asserted-by":"publisher","DOI":"10.1038\/s41408-023-00853-3","volume":"13","author":"N Zhang","year":"2023","unstructured":"Zhang N, Wu J, Wang Q et al (2023) Global burden of hematologic malignancies and evolution patterns over the past 30 years. Blood Cancer J 13(1):82","journal-title":"Blood Cancer J"},{"issue":"Supplement 1","key":"11381_CR2","doi-asserted-by":"publisher","first-page":"3810","DOI":"10.1182\/blood-2023-187856","volume":"142","author":"Z-Y An","year":"2020","unstructured":"An Z-Y, Fu H, He Y et al (2020) Projected global trends in hematological malignancies: incidence, mortality, and disability-adjusted life years from 2020 to 2030. Blood 142(Supplement 1):3810\u20133810","journal-title":"Blood"},{"key":"11381_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/j.blre.2020.100692","volume":"45","author":"TF Gray","year":"2021","unstructured":"Gray TF, Temel JS, El-Jawahri A (2021) Illness and prognostic understanding in patients with hematologic malignancies. Blood Rev 45:100692","journal-title":"Blood Rev"},{"issue":"1","key":"11381_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.soncn.2024.151756","volume":"41","author":"G Mcerlean","year":"2025","unstructured":"Mcerlean G, Ashley C, Pradhan A et al (2025) \u201cIt\u2019s the ride of your life\u201d: a qualitative study on survivor awareness and understanding of blood and marrow transplantation. Semin Oncol Nurs 41(1):151756","journal-title":"Semin Oncol Nurs"},{"issue":"8","key":"11381_CR5","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/j.jtct.2025.05.014","volume":"31","author":"SR Spellman","year":"2025","unstructured":"Spellman SR, Xu K, Oloyede T et al (2025) Current activity trends and outcomes in hematopoietic cell transplantation and cellular therapy - a report from the CIBMTR. Transplant Cell Ther 31(8):505\u2013532","journal-title":"Transplant Cell Ther"},{"issue":"5","key":"11381_CR6","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1038\/bmt.2015.241","volume":"51","author":"J Randall","year":"2016","unstructured":"Randall J, Keven K, Atli T et al (2016) Process of allogeneic hematopoietic cell transplantation decision making for older adults. Bone Marrow Transplant 51(5):623\u2013628","journal-title":"Bone Marrow Transplant"},{"issue":"1","key":"11381_CR7","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.jtct.2021.10.002","volume":"28","author":"VR Bhatt","year":"2022","unstructured":"Bhatt VR, Wang T, Chen K et al (2022) Chronic Graft-versus-Host Disease, nonrelapse mortality, and disease relapse in older versus younger adults undergoing matched allogeneic peripheral blood hematopoietic cell transplantation: a Center for International Blood and Marrow Transplant Research analysis. Transplant Cell Ther 28(1):34\u201342","journal-title":"Transplant Cell Ther"},{"issue":"8","key":"11381_CR8","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1038\/s41409-023-01998-2","volume":"58","author":"J Styczynski","year":"2023","unstructured":"Styczynski J, Tridello G, Koster L et al (2023) Decrease of lethal infectious complications in the context of causes of death (COD) after hematopoietic cell transplantation: COD-2 and COD-1 study of the Infectious Diseases Working Party EBMT. Bone Marrow Transplant 58(8):881\u2013892","journal-title":"Bone Marrow Transplant"},{"key":"11381_CR9","doi-asserted-by":"crossref","unstructured":"Ruan J, Qian Y, Zhuang Y (2023) Survivorship experiences of Chinese hematopoietic stem cell transplantation survivors: a qualitative study [J]. Cancer Nurs. Accessed 13 Feb 2026","DOI":"10.21203\/rs.3.rs-2691540\/v1"},{"key":"11381_CR10","doi-asserted-by":"crossref","unstructured":"Almutairi H, Aboshaiqah A, Alzahrani M et al (2025) The lived experience of adult cancer survivors after hematopoietic stem cell transplantation: a qualitative study from Saudi Arabia [J]. Patient Pref Adher 19(null):279\u2013293","DOI":"10.2147\/PPA.S500554"},{"key":"11381_CR11","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.critrevonc.2015.12.010","volume":"99","author":"C Renzi","year":"2016","unstructured":"Renzi C, Riva S, Masiero M et al (2016) The choice dilemma in chronic hematological conditions: why choosing is not only a medical issue? A psycho-cognitive perspective. Crit Rev Oncol Hematol 99:134\u2013140","journal-title":"Crit Rev Oncol Hematol"},{"issue":"5","key":"11381_CR12","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1016\/S0277-9536(96)00221-3","volume":"44","author":"C Charles","year":"1997","unstructured":"Charles C, Gafni A, Whelan T (1997) Shared decision-making in the medical encounter: what does it mean? (or it takes at least two to tango) [J]. Soc Sci Med 44(5):681\u2013692","journal-title":"Soc Sci Med"},{"key":"11381_CR13","unstructured":"Ottawa Hospital Research Institute. (2024) Patient decision aids research group [Z]. Accessed 20 Oct 2026"},{"issue":"4","key":"11381_CR14","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1161\/CIRCOUTCOMES.113.000350","volume":"7","author":"KR Sepucha","year":"2014","unstructured":"Sepucha KR, Scholl I (2014) Measuring shared decision making. Circ Cardiovasc Qual Outcomes 7(4):620\u2013626","journal-title":"Circ Cardiovasc Qual Outcomes"},{"issue":"7","key":"11381_CR15","first-page":"562","volume":"33","author":"G Pugh","year":"2025","unstructured":"Pugh G, Young L, Yiallouridou C et al (2025) Understanding patient quality of life following haematopoietic cell transplant [J]. Support Care Cancer 33(7):562","journal-title":"Support Care Cancer"},{"key":"11381_CR16","unstructured":"Shi Y, Gao L, Yu JY et al (2023) Meta-synthesis of qualitative research on psychological experience and support needs of patients with hematopoietic stem cell transplantation in purified cabin at different treatment stages [J]. Med Inform 36(17):15\u201321, 33"},{"issue":"1","key":"11381_CR17","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1054\/ejon.2000.0117","volume":"5","author":"L Bywater","year":"2001","unstructured":"Bywater L, Atkins S (2001) A study of factors influencing patients\u2019 decisions to undergo bone marrow transplantation from a sibling or matched related donor [J]. Eur J Oncol Nurs 5(1):7\u201315","journal-title":"Eur J Oncol Nurs"},{"issue":"1","key":"11381_CR18","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.clml.2025.07.002","volume":"26","author":"JF Wu","year":"2026","unstructured":"Wu JF, Akinola IM, D\u2019Souza A et al (2026) A multistakeholder qualitative analysis of barriers to autologous stem cell transplantation for multiple myeloma. Clin Lymphoma Myeloma Leuk 26(1):26\u201333","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"11381_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejon.2024.102684","author":"X Yuan","year":"2024","unstructured":"Yuan X, Yang Y, Wang C et al (2024) Decision-making conflicts regarding hematopoietic stem cell transplantation in patients with hematological neoplasms: a descriptive qualitative study. Eur J Oncol Nurs. https:\/\/doi.org\/10.1016\/j.ejon.2024.102684","journal-title":"Eur J Oncol Nurs"},{"issue":"18","key":"11381_CR20","doi-asserted-by":"publisher","first-page":"1987","DOI":"10.1182\/blood.2024025131","volume":"145","author":"C Gurnari","year":"2025","unstructured":"Gurnari C, Robin M, Ad\u00e8s L et al (2025) Clinical-genomic profiling of MDS to inform allo-HCT: recommendations from an international panel on behalf of the EBMT. Blood 145(18):1987\u20132001","journal-title":"Blood"},{"issue":"11","key":"11381_CR21","doi-asserted-by":"publisher","first-page":"2679","DOI":"10.1002\/cncr.32808","volume":"126","author":"RN Cusatis","year":"2020","unstructured":"Cusatis RN, Tecca HR, D\u2019Souza A et al (2020) Prevalence of decisional regret among patients who underwent allogeneic hematopoietic stem cell transplantation and associations with quality of life and clinical outcomes. Cancer 126(11):2679\u20132686","journal-title":"Cancer"},{"issue":"07","key":"11381_CR22","first-page":"1057","volume":"21","author":"SJ Liu","year":"2021","unstructured":"Liu SJ, Gu JX, Hu W et al (2021) Psychological experience of patients with hematopoietic stem cell transplantation: a meta-synthesis [J]. Chin Nurs Manag 21(07):1057\u20131063","journal-title":"Chin Nurs Manag"},{"issue":"1","key":"11381_CR23","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1007\/s40271-019-00384-9","volume":"13","author":"R Crawford","year":"2020","unstructured":"Crawford R, Sully K, Conroy R et al (2020) Patient-centered insights on treatment decision making and living with acute myeloid leukemia and other hematologic cancers. Patient 13(1):83\u2013102","journal-title":"Patient"},{"issue":"1","key":"11381_CR24","doi-asserted-by":"publisher","DOI":"10.1186\/s13287-025-04766-9","volume":"16","author":"A Nowak","year":"2025","unstructured":"Nowak A, Nadolny S, Jahn F et al (2025) \u2018I had no choice!\u2019 Challenges in the informed consent and decision-making process for allogeneic stem cell transplantation: a qualitative method triangulation. Stem Cell Res Ther 16(1):623","journal-title":"Stem Cell Res Ther"},{"issue":"2","key":"11381_CR25","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1111\/jgs.19276","volume":"73","author":"Q Liu","year":"2025","unstructured":"Liu Q, Li J, Wang L et al (2025) Shared decision-making about autologous stem cell transplantation: a qualitative study of older patients and physicians [J]. J Am Geriatr Soc 73(2):458\u2013469","journal-title":"J Am Geriatr Soc"},{"key":"11381_CR26","unstructured":"JBI (2020) The Joanna Briggs institute critical appraisal tools for use in JBI systematic reviews: checklist for qualitative research[Z]. Accessed 20 Mar 2026"},{"issue":"1","key":"11381_CR27","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2288-12-181","volume":"12","author":"A Tong","year":"2012","unstructured":"Tong A, Flemming K, Mcinnes E et al (2012) Enhancing transparency in reporting the synthesis of qualitative research: ENTREQ. BMC Med Res Methodol 12(1):181","journal-title":"BMC Med Res Methodol"},{"key":"11381_CR28","volume-title":"Handbook for synthesizing qualitative research","author":"M Sandelowski","year":"2007","unstructured":"Sandelowski M (2007) Handbook for synthesizing qualitative research. springer publishing company"},{"issue":"1","key":"11381_CR29","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1111\/j.1365-2648.2007.04569.x","volume":"62","author":"S Elo","year":"2008","unstructured":"Elo S, Kyng\u00e4s H (2008) The qualitative content analysis process. J Adv Nurs 62(1):107\u2013115","journal-title":"J Adv Nurs"},{"key":"11381_CR30","volume-title":"Hoitotieteen teorian kehitt\u00e4minen","author":"S Lauri","year":"2005","unstructured":"Lauri S, Kyng\u00e4s H, Honkala S et al (2005) Hoitotieteen teorian kehitt\u00e4minen, 1. p. ed. WSOY, Porvoo\u202f; Helsinki","edition":"1. p. ed"},{"issue":"10","key":"11381_CR31","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1001895","volume":"12","author":"S Lewin","year":"2015","unstructured":"Lewin S, Glenton C, Munthe-Kaas H et al (2015) Using qualitative evidence in decision making for health and social interventions: an approach to assess confidence in findings from qualitative evidence syntheses (GRADE-CERQual). PLoS Med 12(10):e1001895","journal-title":"PLoS Med"},{"issue":"9","key":"11381_CR32","doi-asserted-by":"publisher","first-page":"e521","DOI":"10.1016\/j.clml.2019.05.003","volume":"19","author":"MA Fiala","year":"2019","unstructured":"Fiala MA, Vij R, Wildes TM (2019) A mixed-methods study of stem cell transplantation utilization for newly diagnosed multiple myeloma. Clin Lymphoma Myeloma Leuk 19(9):e521\u2013e525","journal-title":"Clin Lymphoma Myeloma Leuk"},{"issue":"9","key":"11381_CR33","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.1177\/1049732311405802","volume":"21","author":"R Forsyth","year":"2011","unstructured":"Forsyth R, Scanlan C, Carter SM et al (2011) Decision making in a crowded room: the relational significance of social roles in decisions to proceed with allogeneic stem cell transplantation [J]. Qual Health Res 21(9):1260\u20131272","journal-title":"Qual Health Res"},{"issue":"2","key":"11381_CR34","first-page":"134","volume":"33","author":"DK Hansen","year":"2025","unstructured":"Hansen DK, Bixby T, Fixler K et al (2025) Patient and caregiver perspectives on treatment decision-making for stem cell transplantation in multiple myeloma. Support Care Cancer 33(2):134","journal-title":"Support Care Cancer"},{"issue":"6","key":"11381_CR35","doi-asserted-by":"publisher","DOI":"10.1002\/pon.70185","volume":"34","author":"TQ Nguyen","year":"2025","unstructured":"Nguyen TQ, Le TD, Fan S-Y et al (2025) Exploring relational autonomy of Vietnamese patients\u2019 experiences in decision-making regarding hematopoietic stem cell transplantation: a qualitative interview study. Psychooncology 34(6):e70185","journal-title":"Psychooncology"},{"key":"11381_CR36","doi-asserted-by":"crossref","unstructured":"Sarradon-Eck A, Franchina L, Arnault Y et al (2024) Consenting rather than choosing. A qualitative study on overseas patients\u2019 decision to undergo hematopoietic stem cell transplantation [J]. Cancer Med 13(1):e6934","DOI":"10.1002\/cam4.6934"},{"issue":"5","key":"11381_CR37","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1007\/s12529-022-10126-1","volume":"30","author":"B Yanez","year":"2023","unstructured":"Yanez B, Taub CJ, Waltz M et al (2023) Stem cell transplant experiences among Hispanic\/Latinx patients: a qualitative analysis. Int J Behav Med 30(5):628\u2013638","journal-title":"Int J Behav Med"},{"issue":"1","key":"11381_CR38","volume":"2025","author":"A Reimer","year":"2025","unstructured":"Reimer A, Schepers C, Ley M et al (2025) Navigating what is not known\u2014patients\u2019 experience of the life threat connected to allogeneic stem cell transplantation. Eur J Cancer Care 2025(1):8743444","journal-title":"Eur J Cancer Care"},{"issue":"4","key":"11381_CR39","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1007\/s13187-019-01506-5","volume":"35","author":"J Foster","year":"2020","unstructured":"Foster J, Moore H, Preussler JM et al (2020) Information needs for treatment decision-making of hematopoietic cell transplant patients 65\u00a0years or older and caregivers. J Cancer Educ 35(4):651\u2013660","journal-title":"J Cancer Educ"},{"issue":"02","key":"11381_CR40","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1055\/s-0041-1730091","volume":"42","author":"H Solanki","year":"2021","unstructured":"Solanki H, Tiwari AK, Vashisht N et al (2021) Barriers and support-system while considering hematopoietic stem cell transplant (HSCT): a qualitative study of pre-HSCT acute leukemia patients from a standalone transplant laboratory in India. Indian J Med Paediatr Oncol 42(02):153\u2013160","journal-title":"Indian J Med Paediatr Oncol"},{"key":"11381_CR41","doi-asserted-by":"crossref","unstructured":"Mian O, Puts M, Mccurdy A et al (2022) Decision-making factors for an autologous stem cell transplant for older adults with newly diagnosed multiple myeloma: a qualitative analysis [J]. Front Oncol 12. Accessed 13 Feb 2026","DOI":"10.3389\/fonc.2022.974038"},{"issue":"8","key":"11381_CR42","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15082369","volume":"15","author":"R Cytryn","year":"2023","unstructured":"Cytryn R, Bickell N, Yagnik R et al (2023) What affects treatment underuse in multiple myeloma in the United States: a qualitative study. Cancers (Basel) 15(8):2369","journal-title":"Cancers (Basel)"},{"key":"11381_CR43","doi-asserted-by":"publisher","first-page":"237437352312027","DOI":"10.1177\/23743735231202733","volume":"10","author":"DK Hansen","year":"2023","unstructured":"Hansen DK, Bixby T, Fixler K et al (2023) Experience of autologous stem cell transplant in multiple myeloma: the patient and caregiver perspective [J]. J Patient Exp 10:23743735231202732","journal-title":"J Patient Exp"},{"key":"11381_CR44","unstructured":"Fadem S (2021) Design for sensemaking in complex and ambiguous medical situations [D]. United States -- New Jersey; Rutgers The State University of New Jersey, School of Graduate Studies. Accessed 13 Feb 2026"},{"key":"11381_CR45","unstructured":"Kumasaka LMKB (1991) Factors influencing hazardous decision making related to bone marrow transplant [D]. United States -- Hawaii; University of Hawai'i at Manoa. Accessed 13 Feb 2026"},{"key":"11381_CR46","unstructured":"Haberman MR (1987) Living with leukemia: the personal meaning attributed to illness and treatment by adults undergoing a bone marrow transplantation [D]. United States -- Washington; University of Washington. Accessed 13 Feb 2026"},{"issue":"8","key":"11381_CR47","doi-asserted-by":"publisher","first-page":"2052","DOI":"10.1093\/rheumatology\/kez579","volume":"59","author":"J Spierings","year":"2020","unstructured":"Spierings J, VAN Rhijn-Brouwer FCC, DE Bresser CJM et al (2020) Treatment decision-making in diffuse cutaneous systemic sclerosis: a patient\u2019s perspective. Rheumatology (Oxford) 59(8):2052\u20132061","journal-title":"Rheumatology (Oxford)"},{"issue":"5","key":"11381_CR48","doi-asserted-by":"publisher","first-page":"e206742","DOI":"10.1001\/jamanetworkopen.2020.6742","volume":"3","author":"N Bakshi","year":"2020","unstructured":"Bakshi N, Katoch D, Sinha CB et al (2020) Assessment of patient and caregiver attitudes and approaches to decision-making regarding bone marrow transplant for sickle cell disease: a qualitative study [J]. JAMA Netw Open 3(5):e206742\u2013e206742","journal-title":"JAMA Netw Open"},{"issue":"6","key":"11381_CR49","doi-asserted-by":"publisher","first-page":"3129","DOI":"10.1007\/s00520-020-05816-z","volume":"29","author":"N Leuthold","year":"2021","unstructured":"Leuthold N, Cattaneo M, Halter J et al (2021) Patient preferences for allogeneic haematopoietic stem cell transplantation: how much benefit is worthwhile from the patient\u2019s perspective? Support Care Cancer 29(6):3129\u20133135","journal-title":"Support Care Cancer"},{"key":"11381_CR50","doi-asserted-by":"publisher","DOI":"10.1177\/09636897251393308","volume":"34","author":"X Yu","year":"2025","unstructured":"Yu X, Xiao Z, Li X et al (2025) From risk perception to action: a qualitative study of self-management in hematopoietic stem cell transplant patients. Cell Transplant 34:9636897251393308","journal-title":"Cell Transplant"},{"issue":"4","key":"11381_CR51","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1055\/s-2007-973091","volume":"69","author":"J Ernst","year":"2007","unstructured":"Ernst J, Holze S, Sonnefeld C et al (2007) Medical decision making in hospital - results of an exploratory study on the value of shared decision making from the physicians point of view [J]. Gesundheitswesen 69(4):206\u2013215","journal-title":"Gesundheitswesen"},{"issue":"2","key":"11381_CR52","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1007\/BF00489228","volume":"7","author":"AF Patenaude","year":"1986","unstructured":"Patenaude AF, Rappeport JM, Smith BR (1986) The physician\u2019s influence on informed consent for bone marrow transplantation. Theor Med Bioeth 7(2):165\u2013179","journal-title":"Theor Med Bioeth"},{"issue":"9","key":"11381_CR53","first-page":"2911","volume":"111","author":"TS Olson","year":"2026","unstructured":"Olson TS, Ericson K, Antin JH et al (2026) Preemptive hematopoietic stem cell transplantation in RUNX1 familial platelet disorder: a shared decision-making framework [J]. Haematologica 111(9):2911\u20132923","journal-title":"Haematologica"},{"issue":"11","key":"11381_CR54","doi-asserted-by":"publisher","first-page":"4253","DOI":"10.1007\/s00520-019-04696-2","volume":"27","author":"JM Preussler","year":"2019","unstructured":"Preussler JM, Mau L-W, Majhail NS et al (2019) Caregiver availability and patient access to hematopoietic cell transplantation: social worker perspectives inform practice. Support Care Cancer 27(11):4253\u20134264","journal-title":"Support Care Cancer"},{"issue":"11","key":"11381_CR55","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1016\/j.jtct.2025.06.022","volume":"31","author":"B Tweeten","year":"2025","unstructured":"Tweeten B, Randall J, Barata A et al (2025) The caregiver paradigm in hematopoietic cell transplant: current and future directions. Transplant Cell Ther 31(11):874\u2013888","journal-title":"Transplant Cell Ther"},{"key":"11381_CR56","unstructured":"Anna Desalvo M, CGC, Jaime Preussler, MS (2023) The caregiver impact on access to alloHCT treatment [Z]. Cellgene. Accessed 14 Feb 2026"},{"issue":"11","key":"11381_CR57","doi-asserted-by":"publisher","DOI":"10.1007\/s00520-024-08906-4","volume":"32","author":"JM Preussler","year":"2024","unstructured":"Preussler JM, Desalvo AM, Huberty P et al (2024) Can you spare 100 days? The allogeneic hematopoietic cell transplant caregiver requirement from the perspective of social workers. Support Care Cancer 32(11):723","journal-title":"Support Care Cancer"},{"issue":"1","key":"11381_CR58","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-021-08527-8","volume":"21","author":"C Pritlove","year":"2021","unstructured":"Pritlove C, Jassi M, Burns B et al (2021) The work of managing multiple myeloma and its implications for treatment-related decision making: a qualitative study of patient and caregiver experiences. BMC Cancer 21(1):793","journal-title":"BMC Cancer"},{"issue":"11","key":"11381_CR59","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1093\/oncolo\/oyae187","volume":"29","author":"A Gupta","year":"2024","unstructured":"Gupta A, Brundage MD, Galica J et al (2024) Patients\u2019 considerations of time toxicity when assessing cancer treatments with marginal benefit. Oncologist 29(11):978\u2013985","journal-title":"Oncologist"},{"key":"11381_CR60","doi-asserted-by":"publisher","DOI":"10.1016\/j.apjon.2024.100610","author":"C Nwozichi","year":"2024","unstructured":"Nwozichi C, Omolabake S, Ojewale MO et al (2024) Time toxicity in cancer care: a concept analysis using Walker and Avant\u2019s method. Asia Pac J Oncol Nurs. https:\/\/doi.org\/10.1016\/j.apjon.2024.100610","journal-title":"Asia Pac J Oncol Nurs"},{"issue":"2","key":"11381_CR61","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.3390\/curroncol28020117","volume":"28","author":"N Iragorri","year":"2021","unstructured":"Iragorri N, DE Oliveira C, Fitzgerald N et al (2021) The out-of-pocket cost burden of cancer care-a systematic literature review. Curr Oncol 28(2):1216\u20131248","journal-title":"Curr Oncol"},{"issue":"6","key":"11381_CR62","doi-asserted-by":"publisher","first-page":"3807","DOI":"10.3390\/curroncol29060305","volume":"29","author":"C Parker","year":"2022","unstructured":"Parker C, Berkovic D, Ayton D et al (2022) Patient perceived financial burden in haematological malignancies: a systematic review. Curr Oncol 29(6):3807\u20133824","journal-title":"Curr Oncol"},{"issue":"1","key":"11381_CR63","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.soc.2021.08.001","volume":"31","author":"RA Greenup","year":"2022","unstructured":"Greenup RA (2022) Financial toxicity and shared decision making in oncology. Surg Oncol Clin N Am 31(1):1\u20137","journal-title":"Surg Oncol Clin N Am"},{"issue":"9","key":"11381_CR64","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1200\/OP.24.00016","volume":"20","author":"MA Fiala","year":"2024","unstructured":"Fiala MA (2024) Financial toxicity and willingness-to-pay for cancer treatment among people with multiple myeloma. JCO Oncol Pract 20(9):1263\u20131271","journal-title":"JCO Oncol Pract"},{"issue":"10","key":"11381_CR65","first-page":"862","volume":"33","author":"J Jing","year":"2025","unstructured":"Jing J, Li M, Rui Y et al (2025) The weight of time: experience of time toxicity among advanced cancer patients and their family caregivers-a qualitative study. Support Care Cancer 33(10):862","journal-title":"Support Care Cancer"},{"issue":"10","key":"11381_CR66","first-page":"1586","volume":"24","author":"X Liu","year":"2024","unstructured":"Liu X, Hu W, Wei Y (2024) Research progress on returning to work among survivors of hematopoietic stem cell transplantation [J]. Chin Nurs Manag 24(10):1586\u20131591","journal-title":"Chin Nurs Manag"},{"issue":"4","key":"11381_CR67","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1016\/j.hemonc.2017.05.009","volume":"10","author":"NS Majhail","year":"2017","unstructured":"Majhail NS (2017) Long-term complications after hematopoietic cell transplantation. Hematol Oncol Stem Cell Ther 10(4):220\u2013227","journal-title":"Hematol Oncol Stem Cell Ther"},{"key":"11381_CR68","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.cd007569.pub3","author":"AG DE Boer","year":"2015","unstructured":"DE Boer AG, Taskila TK, Tamminga SJ et al (2015) Interventions to enhance return-to-work for cancer patients. Cochrane Database Syst Rev. https:\/\/doi.org\/10.1002\/14651858.cd007569.pub3","journal-title":"Cochrane Database Syst Rev"},{"issue":"12","key":"11381_CR69","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1016\/j.jtct.2022.09.017","volume":"28","author":"RB Salit","year":"2022","unstructured":"Salit RB, Schoeppner K, DE Biase C et al (2022) American Society for Transplantation and Cellular Therapy Return to Work Guidance Committee recommendations for health care providers who take care of hematopoietic cell transplantation patients. Transplant Cell Ther 28(12):822\u2013828","journal-title":"Transplant Cell Ther"},{"issue":"5","key":"11381_CR70","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1007\/s11764-021-01092-w","volume":"16","author":"S Kurosawa","year":"2022","unstructured":"Kurosawa S, Yamaguchi T, Mori A et al (2022) Resignation and return to work in patients receiving allogeneic hematopoietic cell transplantation close up [J]. J Cancer Surviv 16(5):1004\u20131015","journal-title":"J Cancer Surviv"}],"container-title":["Supportive Care in Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-026-11381-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00520-026-11381-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-026-11381-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T23:03:47Z","timestamp":1792796627000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00520-026-11381-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,23]]},"references-count":70,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["11381"],"URL":"https:\/\/doi.org\/10.1007\/s00520-026-11381-8","relation":{},"ISSN":["0941-4355","1433-7339"],"issn-type":[{"value":"0941-4355","type":"print"},{"value":"1433-7339","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,23]]},"assertion":[{"value":"14 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 September 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 October 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 October 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable. This study is a systematic review of existing published literature and does not involve original human or animal data collected by the authors. Therefore, ethics approval was not required.","order":1,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":3,"name":"Ethics","label":"Consent to publish","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"1149"}}